12 Top Automation (RPA) Tools List

The use of RPA is to increase organizational productivity and efficiency. So that they can automate routine operations. As I said RPA is leading in Finance and  Insurance domains.

The term BPA is nothing but Business process automation.

12 Top Automation (RPA) Tools List
12 Top Automation (RPA) Tools List

List of Automation Tools

  1. Blue Prism
  2. Contextor
  3. EdgeVerve Systems
  4. Kofax
  5. Kryon Systems
  6. NICE
  7. Pegasystems
  8. Redwood Software
  9. Softomotive
  10. UiPath
  11. WorkFusion
  12. Automation Anywhere

According to Forester research there are only 3 tools leading in Automation market:

Automation Anywhere, Blue Prism, And UiPath Lead The Pack-Forrester’s research uncovered a market in which Automation Anywhere, Blue Prism, and UiPath are Leaders. WorkFusion, Pegasystems, NICE, Kryon, EdgeVerve, and Redwood are Strong Performers with competitive options. Kofax, Contextor, and Softomotive are Contenders.

Popular Tools

  • Blue Prism
  • UiPath
  • Automation anywhere

Blue Prism is built on the Microsoft .NET Framework. It automates any application and supports any platform (mainframe, Windows, WPF, Java, web, etc.) presented in a variety of ways (terminal emulator, thick client, thin client, web browser, Citrix and web services).

Blue Prism designed for a multi-environment deployment model (development, test, staging, and production) with both physical and logical access controls.

Blue Prism RPA software includes a centralised release management interface and process change distribution model providing high levels of visibility and control. Additional control is provided to the business via a centralised model for process development and re-use.

The software supports regulatory contexts such as PCI-DSS, HIPAA and SOX, with a large number of controls in place to provide the necessary security and governance.

Related Posts

Author: Srini

Experienced Data Engineer, having skills in PySpark, Databricks, Python SQL, AWS, Linux, and Mainframe

Comments are closed.